WHO set to resume hydroxychloroquine trial to battle covid-19

Video Credit: HT Digital Content
Published on June 4, 2020 - Duration: 02:33s

WHO set to resume hydroxychloroquine trial to battle covid-19

World Health Orgnanisation (WHO) said hydroxychloroquine (HCQ) will return to solidarity trial for potential treatment covid-19.

The UN body had paused trials of the anti-malarial drug citing a Lancet study.

The study had suggested the drug could cause more fatalities among Covid-19 patients.

At a press conference in the WHO headquarters in Geneva, Director General Tedros Adhanom Ghebreyesus said, “The Executive Group received this recommendation and endorsed continuation of all arms of the solidarity trial, including hydroxychloroquine.” Watch the video for more.

Advertisement

You are here

Related videos from verified sources

FDA Pulls Emergency Authorization For Hydroxychloroquine 00:37
Video credit: Wochit Entertainment - Published on June 15, 2020 

Tampa General Hospital|Morning Blend 06:13
Video credit: ABC Action News - Published on June 11, 2020 

'WHO should've researched independently’: CSIR welcomes HCQ trial resumption 01:41
Video credit: HT Digital Content - Published on June 4, 2020 

You might like